Get real-time updates on Telegram
CVE-2025-63829: fast dds through 3.3.0 (inclusive); +1 more affected products
CVE-2025-63829. CVSS 3.1 base score 7.5 (HIGH, NVD). EPSS 0.00339 (percentile 0.27106), scored 26-Oct-2026.
Affected technology
fast dds · through 3.3.0 (inclusive)
eprosima
n/a · n/a
Vendor not specified by the source
Description’s affected range: before
Component: Not specified by the source
Attack conditions (NVD, CVSS 3.1): Network (remote) · No privileges required · No user interaction required
Attack conditions (Source advisory, CVSS 3.1): Network (remote) · No privileges required · No user interaction required
What an attacker can do
NVD’s CVSS 3.1 assessment (base score 7.5/10) rates confidentiality and integrity impact as none; availability impact as high. Source advisory’s CVSS 3.1 assessment (base score 5.3/10) rates confidentiality impact as low; integrity and availability impact as none. The description does not specify what an attacker can achieve beyond these rated impacts.
- CWE
- CWE-190, CWE-835
- CCR priority
- 30.1 /100 (P4)
- CVSS 3.1
- 7.5 /10 · CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H · NVD
- EPSS
- 0.00339 · percentile 0.27721 · 2026-11-15
- KEV
- no
Provenance
- FIRST EPSS daily exploit-probability · Source record · observed 2026-11-16 06:41:02.068004+00:00 UTC
- NVD CVE API 2.0 · Source record · observed 2026-11-05 14:54:18.558701+00:00 UTC
Stable permalink: https://cybercodered.org/item/cve-cve-2025-63829.html